KEYWAY

Welcome to the Brand page for “KEYWAY”, which is offered here for Conducting scientific research for others in the fields of pharmaceutical discovery, pharmaceutical research and development, pharmaceuticals, biotechnology, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics; conducting scientific research for others in the fields of engineered proteins, t cell receptors, artificial t cell receptors, antibody-based mimics of t cell receptors (tcr mimics), chimeric antigen receptors, biopharmaceuticals, biotherapeutics, immunotherapeutics, cell-based therapeutics, t cell therapeutics, genetic engineering, genome modulation, and genome editing; conducting scientific research for others in the field of cellular immunotherapy programs utilizing engineered t cells;.

Its status is currently believed to be active. Its class is unavailable. “KEYWAY” is believed to be currently owned by “Alloy Therapeutics, Inc.”

Owner:
ALLOY THERAPEUTICS, INC.
Owner Details
Description:
Conducting scientific research for others in the fields of pharmaceutical discovery, pharmaceutical research and development, pharmaceuticals, biotechnology, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics; Conducting scientific research for others in the fields of engineered proteins, T cell receptors, artificial T cell receptors, antibody-based mimics of T cell receptors (TCR mimics), chimeric antigen receptors, biopharmaceuticals, biotherapeutics, immunotherapeutics, cell-based therapeutics, T cell therapeutics, genetic engineering, genome modulation, and genome editing; Conducting scientific research for others in the field of cellular immunotherapy programs utilizing engineered T cells;
Categories: CONDUCTING SCIENTIFIC RESEARCH OTHERS